Prognostic factors for liver, blood and kidney adverse events from glucocorticoid sparing immune-suppressing drugs in immune-mediated inflammatory diseases: a prognostic systematic review
Background Immune-suppressing drugs can cause liver, kidney or blood toxicity. Prognostic factors for these adverse-events are poorly understood.Purpose To ascertain prognostic factors associated with liver, blood or kidney adverse-events in people receiving immune-suppressing drugs.Data sources MED...
Saved in:
| Main Authors: | Abhishek Abhishek, Danielle van der Windt, Christopher Carroll, Matthew J Grainge, Richard Riley, Joanna Leaviss, Munira Essat, Tim Card |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-02-01
|
| Series: | RMD Open |
| Online Access: | https://rmdopen.bmj.com/content/10/1/e003588.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation
by: Abhishek Abhishek, et al.
Published: (2024-02-01) -
LINC00892 as a Prognostic Biomarker in Lung Adenocarcinoma: Role in Immune Infiltration and EMT Suppression
by: Xinyu Luan, et al.
Published: (2025-01-01) -
TOPK promotes immune suppression in kidney renal clear cell carcinoma and emerges as a prognostic and therapeutic target
by: Zeyuan Zheng, et al.
Published: (2025-08-01) -
Prognosis Research Strategy (PROGRESS) 3: prognostic model research.
by: Ewout W Steyerberg, et al.
Published: (2013-01-01) -
Multi-omics analysis reveals glutathione metabolism-related immune suppression and constructs a prognostic model in lung adenocarcinoma
by: Yuxiang Chi, et al.
Published: (2025-07-01)